Skip to main content

UPSHER-SMITH 0227 30 mg (Morphine Sulfate Extended-Release 30 mg)

Pill with imprint UPSHER-SMITH 0227 30 mg is Purple, Capsule-shape and has been identified as Morphine Sulfate Extended-Release 30 mg. It is supplied by Upsher-Smith Laboratories, Inc.

Morphine is used in the treatment of chronic pain; neonatal abstinence syndrome; pain and belongs to the drug class narcotic analgesics. Risk cannot be ruled out during pregnancy. Morphine 30 mg is classified as a Schedule 2 controlled substance under the Controlled Substance Act (CSA).

Images for UPSHER-SMITH 0227 30 mg

Morphine sulfate extended-release 30 mg UPSHER-SMITH 0227 30 mg
Morphine sulfate extended-release 30 mg UPSHER-SMITH 0227 30 mg Front
Morphine sulfate extended-release 30 mg UPSHER-SMITH 0227 30 mg Back
Morphine sulfate extended-release 30 mg UPSHER-SMITH 0227 30 mg

Morphine Sulfate Extended-Release

Imprint
UPSHER-SMITH 0227 30 mg
Strength
30 mg
Color
Purple
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Narcotic analgesics
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
2 - High potential for abuse
Labeler / Supplier
Upsher-Smith Laboratories, Inc.
National Drug Code (NDC)
00832-0227
Inactive Ingredients
microcrystalline cellulose, methacrylic acid - ethyl acrylate copolymer (1:1) type a, polyethylene glycol 4000, diethyl phthalate, magnesium silicate, titanium dioxide, FD&C Blue No. 1, FD&C Red No. 40

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.